Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casopitant in Primary Insomnia
NCT00650871Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of casopitant in Insomnia, sponsored by GSK. Started Jul 2004; status: completed.
02
Drugs
casopitant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00650871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650871.